See How IQVIA AI is Advancing Healthcare Today
IQVIA AI can help you…
… find more product eligible patients
Client Case Studies: AI-Powered Disease Modeling
Several actual client case studies demonstrate the dramatic results IQVIA AI-powered modelling can achieve, helping one client double the number of identified product-eligible patients, and another to predict 81% of patients likely to discontinue a treatment early.
… get rapid insights into real world effectiveness
Case Studies Show How AI Helped Establish Product Effectiveness
Several IQVIA respiratory case studies demonstrate how AI and ML algorithms helped our clients improve patient outcomes. increase treatment transition rates, and establish product effectiveness in the real world, while developing rapid and clear insights into treatment outcomes, patient journeys, and HCP caseloads.
… drive commercial success
Animated Infographic: The Many Ways AI Improves Results
See how IQVIA’s platform of interconnected apps is being used to drive unprecedented results, elevate customer engagement, help find more of the right patients and the HCPs treating them, and help sales teams by delivering the right messaging, at the most effective time.
… improve product switch rate 500%
Case Study: See How AI Accelerated Commercial Success
This case study shows how AI and machine learning (ML) were used to correctly identify more eligible patients and precisely targeted HCPs for our client's biologic treatment. This accelerated our client’s commercial success, and dramatically improved the switch rate to their specialty drug treatment with a 5x greater rate of treatment transition vs previous methods.
… predict disease progression
White Paper on Effectively Using AI to Predict Disease Progression
This client case study shows how AI helped deliver messages to those HCPs most likely to be the change-of-therapy decision makers for specific patient groups, by identifying leverageable patterns and interactions that would otherwise go unnoticed.
… identify key patient events, realize product value
AI Predicted 81% of MS Patients Likely to Discontinue Treatment Early
In this case study, IQVIA's AI-powered modelling successfully predicted 81% of patients likely to discontinue treatment early. Our client was then able to formulate new business strategies to address identified issues and improve patient adherence helping to realize their product’s true value.
… drive better HCP conversations
Podcast and Blog Article on How AI is Changing Medical Affairs
AI and Real World Data (RWD) can help foster better connections with medical professionals by giving Medical Affairs professionals new and deeper insights about treatment effectiveness, disease progression, and patient outcomes. Hear the podcast or read the blog article. Both address how Medical Affairs can improve the use of RWD and AI today.
… quickly draw market insights & optimize care
Case Study: AI & Machine Learning Improved HCP Targeting
This case study shows how a large pharmaceutical company quickly identified HCPs treating diabetic patients with comorbid obesity leveraging. Using IQVIA’s machine learning apps the client was able to rapidly draw market insights, identify the specific patients and HCPs, and ultimately to optimize care. The project relied on use of IQVIA’s rich, claims-based US healthcare data assets.
… supercharge brand growth with alerts (US)
Webinar: Leverage AI to Drive Precise and Timely HCP Alerts
See how to Leverage the power of artificial intelligence (AI) and machine learning (ML) based models to more accurately identify potential patients (e.g. undiagnosed, or eligible for next line of therapy).
… dramatically improve patient profiling
Case Study Shows How IQVIA Identified 30% More Target Patients
This client case study shows how IQVIA’s AI/ML-powered analytics, improved precision respiratory patient targeting by 30%, finding more patients with uncontrolled asthma for the client’s respiratory treatment. Additional analysis led to further improvements in accurate patient profiling and effective physician targeting.
… drive commercial success in Europe
White Paper Shows How AI Still Delivers Within EU Privacy Rules
This white paper shows how pharma can harness AI & machine learning to analyze vast customer data sets while still adhering to Europe’s data privacy laws. Advances in AI & machine learning, combined with healthcare data from pharmacies, insurers, healthcare professionals (HCP), labs, marketing campaigns, and social media, are providing companies with a competitive edge.
… get continual patient level insights
Podcast and Blog Article on Instant Insights Reporting
IQVIA’s Instant Insight reports go far beyond what static reports offer, allowing different users to iteratively drill into the data and continually refresh to stay up to date. Dynamic reports are suitable notjust for brand teams, but also for medical affairs, and medical technology teams. Hear the podcast or read the blog article.
… accelerate brand adoption (in EU)
Webinar Shows How to Continuously Proactively Identify Opportunities
This webinar shows how to leverage the power of connected intelligence by maximizing the use of the latest RWD, advanced analytics, scalable technologies, and therapeutic SME to accelerate brand adoption by continuously and proactively identifying your true opportunities across diseases areas and markets.
… increase sales for efficiency and effectiveness
Case Study Shows How AI Improved Physician Targeting Accuracy
IQVIA’s dynamic HCP segmentation harnesses the power of IQVIA’s vast Real World Data (RWD) assets, and our extensive AI and Machine Learning (ML) expertise, to segment HCPs based on multiple factors to provide dynamic, up-to-date HCP profiling and targeting for effective sales force allocation.
